SNTI 10-Q: SEC filing
Senti Biosciences
Filed with the SEC on · accession 0001628280-26-074183
SNTI filed a 10-Q (quarterly report) with the SEC on Nov 16, 2026. The quarterly report: unaudited results for the quarter plus management’s comments.
Summary of the filing
Senti Biosciences filed its Q3 2026 Form 10-Q, reporting continued net losses and a going-concern uncertainty, alongside a July 2026 merger agreement and related contingent value rights, plus new senior secured convertible note financings.
Key details
✦ Ask GOAX AI about this filing — what it means for SNTI, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SNTI?
Click hereFrequently asked questions
What did SNTI file with the SEC on Nov 16, 2026?
SNTI filed a 10-Q (SEC filing). Senti Biosciences filed its Q3 2026 Form 10-Q, reporting continued net losses and a going-concern uncertainty, alongside a July 2026 merger agreement and related contingent value rights, plus new senior secured convertible note financings.
How do I read a 10-Q?
The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.
Other SNTI SEC filings
- SCHEDULE 13G/A · SEC filingNov 13, 2026
- 8-K · Material agreementNov 10, 2026
- 8-K · SEC filingOct 27, 2026
- 8-K · AcquisitionOct 26, 2026
- 8-K · SEC filingOct 15, 2026
- 8-K · SEC filingOct 13, 2026
- 8-K · SEC filingSep 24, 2026
- EFFECT · SEC filingSep 24, 2026
- 424B3 · Secondary offeringSep 24, 2026
- S-3 · Shelf registrationSep 22, 2026
Get alerts when SNTI files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days